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The steps  involved in the  maturation of normal bone marrow-derived (B) 
lymphocytes into immunoglobulin (Ig)-secreting plasma cells  after  antigenic 
or mitogenic stimulation have been described according to cellular morphology 
in morphology in electron micrographs  (1,  2),  immunofluorescent analysis of 
surface-bound and  intracytoplasmic Ig  (3),  and  biochemical studies  of  IgM 
synthesis, surface  representation, and secretion  (4-6).  In the  present studies 
the  state  of  maturation  of  cells  obtained  from  five  routine  IgM-producing 
lymphocytomas has been characterized by a variety of morphological and bio- 
chemical criteria. The degree of maturity of each of these cell populations has 
been assessed by comparison to normal mitogen-stimulated B lymphocytes. 
Materials and Methods 
Turnors.--Mouse tumors  transplantable  in  BALD/c-mice were obtained  from Doctors 
K. R. Mclntire and M. Potter,  National Cancer Institute, NIH, Bethesda, Md. (McPc 1748, 
TEPC 183, and McPc 774) or from Doctors Melvin Cohn and Judith Hirst at the Salk Insti- 
tute, La Julia, Calif. (Y 5781, W 3469). Tumors were grown subcutaneously. 
Morphology.--Animals were sacrificed by exsanguination under  light  ether  anaesthesia. 
Sera were collected and stored for serologic studies. Organs were examined in situ or removed 
aseptically for further  studies. Subcutaneous tumors were prepared for morphologic studies 
by four methods.  Imprints were made from freshly cut tumor  surfaces and stained  with 
Wright's and Giemsa stains. Blocks 30-50 mm on a side were fixed in 109~ formalin, embedded, 
cut, and stained with hematoxylin and eosin. Cell suspensions were spun in a cytocentrifuge 
and stained with Wright's  and Giemsa stains. Additional fresh tumor was cut into 1 2 mm 
cubes, placed in 1.5% glutaraldehyde in 0.1 ml sodium cacodylate, coded, and prepared for 
electron microscopy (7). 
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Immunofluoreseence.-- 
Antisera:  A  specific antimouse/z-chain antiserum was  raised  in rabbits by injection of 
purified IgM mouse myeloma protein MOPC 104, followed by absorption of the serum with a 
mixture of purified IgG, and IgA myeloma proteins, made insoluble by  cross-linking  with 
ethylchloroformate (8). The specificity of the antiserum was assessed by immunodiffusion in 
agarose gel.  A  further control for specificity was performed after  conjugation  with  fluoro- 
chrome by staining of IgM and IgG plasma cells.  The antiserum did not stain an IgGl-pro- 
ducing myeloma cell line, which was stained both on the membrane and in the cytoplasm by a 
specific anti-IgG1  antiserum.  The  IgG  fraction of  the antiserum,  prepared  by  ammonium 
sulfate precipitation and DEAE chromatography, was labeled with fluorescein or rhodamine 
isothiocyanate (Baltimore Biological Labs.,  Baltimore, Md.)  according to Cebra and  Gold- 
stein (9). 
Staining  o/cells:  Cell  suspensions were  prepared  from  the solid  tumors by  teasing on 
stainless steel gauze. After allowing spontaneous sedimentation of cell clumps, the suspensions 
were washed twice in the cold in Hank's balanced salt solution -F 10% fetal calf serum. 
Double staining of cells for surface and intracytoplasmic immunoglobulins was performed 
as described by Pernis et al. (3). Briefly, the cell suspensions were incubated in the cold with 
an equal vol of rhodamine-conjugated antiserum for 30 min in an ice bath, and washed three 
times with cold medium. The pellet was  then resuspended in 3% bovine serum albumin in 
phosphate-buffered saline (PBS) 1 and smeared on slides by means of a  Shandon-Elliot cyto- 
centrifuge (Shandon Scientific Co.,  Inc., Sewickley, Pa.).  The cell smears were fixed  for  10 
min in 95% ethanol, rehydrated in several changes of PBS, and exposed  to the fluorescein- 
conjugated antiserum for 45 min at room  temperature in a  moist chamber. After thorough 
washing in PBS, the slides were mounted in phosphate-buffered glycerol. 
Microscopy:  The  preparations  were  observed  under  a  Leitz  Orthoplan  microscope 
equipped with an Opak-Fluor vertical Illuminator (Leitz GmbH, Wetzlar, Germany), using 
selective illumination for fluorescein or rhodamine (10). Photographs were recorded on Kodak- 
Tri Pan 23 DIN black-white film. 
Biosynthetic  St~uties.--Preparation  of cell suspensions, cell viability determinations, label- 
ing  of  cells with L-[4,5-3H]leucine  (50  Ci/mmol,  66 #Ci/ml,  batch  40),  n-[1-3Hlmannose 
(3.3 Ci/mmol, 50/zCi/ml, batch 13), D-[1-3H]galactose  (5.7 Ci/mmol, 50 ~Ci/ml, batch 13) and 
L-[l-3H]fucose (2.82  Ci/mmol, 50/zCi/ml, batch 5), all from the Radiochemical Centre, Amer- 
sham, England), separation of the labeled cells from their supernatant medium, lysis of cells 
with Nonidet P40 (NP-40, Shell Chemical Co., Ztirich, Switzerland),  nonionic detergent,  di- 
alysis of cell lysates and supernatant media, centrifugation of the dialyzed lysates at 22,000 
g  for  2  h, determinations of  total radioactivity  incorporated  into  macromolecular,  nondi- 
alyzable  material,  and  into  serologically  precipitable material  have  been  described  else- 
where (4, 5). Serological precipitations were done by reacting soluble complexes of radioactive 
mouse  myeloma  IgM  and  excess  rabbit (antimouse Ig)  antiserum with pig  (antirabbit Ig) 
globulin  at  equivalence  point  (sandwich  technique).  We  are  grateful  to  Dr.  F.  Franek, 
Czechoslovak Academy of  Sciences,  Prague,  Czechoslovakia, for supplies of  the  pig  serum. 
Values  obtained with specific  (antimouse  Ig)  precipitations  were corrected  by  subtracting 
from values obtained with nonspecific  (anti-E.  coli/3-galactosidase)  precipitations. All sero- 
logical determinations were done at least in duplicate. The IgM-specific antisera were raised 
in rabbits by repeated  injections of  1 mg each of purified (11) extracellular 19S MOPC 104E 
IgM (~,/z). The specificity of  these antisera has been described (6, 12).  Size and  polypeptide 
chain composition of  the radioactive  IgM was determined in intracellular lysates or  extra- 
cellular fluids by sucrose gradient sedimentation followed by serological analysis of the sucrose 
gradient fractions  (6,  11),  or  was  determined in serological precipitates from the intracell- 
l Abbre'~,iations used in  this  paper:  EM,  electron  microscopy;  LPS,  lipopolysaccharide; 
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ular lysates and the extracellular fluids containing the radioactive mouse IgM by polyacryla- 
mide gel electrophoreses. Composite gels (13) of 2.5% cross-linked polyacrylamide in 0.5% 
agarose were used for the dissociated serological precipitates  for size analysis of the radio- 
active  IgM,  while 7.5%  cross-linked polyacrylamide  gels (14) were used for  the  disso- 
ciated, reduced, and alkylated  serological precipitates  for analysis of the po]ypeptide chain 
composition of radioactive mouse IgM. Both gel procedures were adapted  to the soluble gel 
procedure of Choules and Zimm (15). Quantitative determinations of radioactivity  in differ- 
ent neutral hexoses and hexosamines were done by column chromatography on Dowex 2 (X 8) 
(neutral hexoses [16]) (Dowex Ion Exchange Resins, Dow Chemical Co., Midland,  Mich.), 
and on Amberlite CG-120 (hexosamines [17]) (Amberlite Cation  & Anion Exchange Resins, 
Rohm and Haas Co., Philadelphia) with hydrolysates and serological precipitates  of radio- 
active myeloma protein as described (18). Actinomycin D was obtained from Sigma Chemical 
Co., St. Louis, Mo. 
RESULTS 
Biologic Behavior of Tumors.--McPc  1748  was obtained as a  splenic tumor. 
The tumor grew only in the spleen whether it was inoculated subcutaneously 
or intraperitoneally. After the fourth passage in our laboratory a small nodule 
was noted at  the site of injection of the  tumor cells. The nodule was excised 
and passed subcutaneously. After three additional passages the tumor grew as 
well subcutaneously as it did in the spleen. Studies of IgM synthesis with cells 
obtained from both sites in the same animal yielded virtually identical results 
with respect to the amount of IgM synthesized relative to total cell protein and 
the pattern of assembly and secretion. All animals with subcutaneous tumors 
had enlarged, grossly infiltrated spleens at the time of sacrifice. 
W 3469 and Y 5781 grew both subcutaneously and in the spleen while animals 
with the TEPC  183  and McPc 774 tumors had some splenic enlargement but 
no gross  infiltration. When minced spleens from  mice bearing the  latter  two 
tumors were injected into new animals, either intraperitoneally or subcutane- 
ously, tumors appeared in 20  50% of the animals. Hence the degree of splenic 
colonization achieved by cells from these two tumors appeared to be somewhat 
less than that of the others. Mean survival times were ascertained by the sub- 
cutaneous injection of 10  ~ viable tumor cells per animal into groups of six-ten 
animals per tumor and observing the animals daily until death (Table I). 
TABLE I 
Characterization of Five IgM-Producing  Mouse Tumors 
Tumor 
Med.  Immunofluoresce  nce 
Group surv.  time  Splenic  (days)  homing  Cytoplasmic Membrane- 
IgM  bound IgM 
Electron microscopy 
Free  Bound  A-particles  polysomes  polysomes 
1748  I  30  4-4-+  4-  4-4-+  4-4-+  --  -- 
3469  I  21  4-4-+  4-  +4-4-+  +4-4-  --  -- 
5781  II  28  4-4-  4-4-+  4-  4-4-  4-4-  4- 
774  II  <50  4-  4--t-4-4-  --  4-  4-4-4-4-  4-4-4- 
183  II  23  4-  4-4-4-  --  4-  4-4-4-4-  4-4-4-4- ANDERSSON  ET  AL.  745 
Immunofluorescence.--All tumors  gave  suspensions  of large  cells,  with  the 
nucleus of considerable size. However, the average cell  diameter was smaller 
in tumors McPc 1748 and W 3469 than in TEPC 183, McPc 774, and Y 5781. 
The first two tumors had in addition relatively less cytoplasm and on the whole 
the  appearance  of  these  cells  was  more  that  of  intermediate  lymphocytes, 
whereas TEPC 183, McPc 774, and Y 5781 tumor cells had the appearance of 
large "blast" cells with a relative increase of the proportion of cytoplasm over 
nucleus. 
Striking  differences between  the  tumors  were  obvious with  regard  to  the 
surface  and  intracytoplasmic  immunoglobulins.  Here  again  two  groups  of 
tumors were apparent: McPc 1748 and W  3469 showed abundant membrane- 
bound and scanty intracytoplasmic immunogloblins  (see  Fig.  1  a  and b).  It 
should be remembered that  restaining of membrane immunoglobulins  in the 
second step in this staining procedure may generate an increased intensity of 
the second staining not due to intracytoplasmic immunoglobulins. 
On  the other hand  the membrane immunofluorescence showed only a  few 
spots on the cells of tumors TEPC  183  and McPc 774,  and none at all on Y 
5781 cells; these last three tumors, by contrast, had abundant intracytoplasmic 
immunoglobulins, so that the pattern of intracytoplasmic staining was similar 
to that of plasmablasts or young plasma cells (Fig. 1 c  e). 
Electron Microscopy (EM).--At  least  400-500  cell  profiles of  each  tumor 
were examined on three occasions with the microscopist unaware of the iden- 
tity of the individual tumors. The results for each tumor were identical on each 
occasion. 
Using cytoarchitectural features the tumors could be divided into two major 
groups  (Fig.  2). The majority of cells  in group I  tumors  (McPc  1748  and W 
3469)  contained  numerous  cytoplasmic  polysome  clusters.  There  was  little 
rough endoplasmic  reticulum  and  the  golgi  zones  were  quite  small.  Many 
mitochondria were present. The nuclei had large areas of electron dense, clumped 
heterochromatin, a  feature similar  to  that  seen  in  the  resting  small  lym- 
phocyte (Fig. 2 a and b). About 10%  of cell  profiles were lymphoblastoid or 
mitotic cells. 
Group II tumors, of which McPc 774 and TEPC 183 were typical, were com- 
prised predominantly of larger cells with much smaller nuclear to cytoplasmic 
ratios. Although many polysome aggregates were noted free in the cytoplasm, 
an  extensively developed rough  endoplasmic  reticulum  (RER)  with  various 
states  of  cisternal  dilatation  was  prominent.  The  golgi  was  extremely well 
developed  and  again  many  mitochondria  were  present.  Many  of  tbe  cells 
showed prominent nucleoli and large areas of adielectronic euchromatin (Fig. 
3  a  and b).  10-20% of the cell  profiles had the electron microscopic features 
of small lymphocytes, lymphoblasts, mature plasma cells, and mitotic cells. 
Y  5781  contained  cells  with  moderately  developed  RER  and  moderate 
numbers  of  cytoplasmic polysome aggregates.  Y  5781  cells  appeared  to  be Fie. 1.  Mouse tumor cells, stained in suspension with a rhodamine-conjugated antimouse 
N-chain antiserum, flattened on slides,  and stained after fixation with the same antiserum 
conjugated  with  fluorescein.  (A)  Phase  contrast;  (B)  Specific  visualization  of  rhodamine 
(surface immunoglobulins only);  (C)  Specific  visualization of fluorescein  (intracytoplasmic 
immunoglobulins plus some restaining of surface immunoglobulins). (a) Tumor McPc 1748: 
bright staining of surface immunoglobulins (B) and weak staining after fixation (C),  mostly 
due  to  restaining of surface immunoglobulins; (b)  Tumor  W  3469:  the cells  show definite 
staining of surface immunoglobulins, and some staining of the cytoplasm; (c) Tumor TEPC 
183: the surface immunoglobulins are very scanty, but still detectable as few spots, whereas 
intracytoplasmic immunoglobulins are  clearly  detectable;  (d)  Tumor  McPc  774: surface 
immunoglobulins are barely detectable on a  few ceils,  that by contrast contain appreciable 
amounts of immunoglobulins in the cytoplasm; (e) Tumor Y 5781: the cells appear devoid of 
surface immunoglobulins, as detectable by immunofluorescent staining, and contain consider- 
able amounts of intracytoplasmic immunoglobulins. 
746 FIG. 2.  (a)  Cell  from  McPc  1748.  Note  the  numerous  cytoplasmic  polysome  clusters 
(arrows) and occasional strands of rough surfaced endoplasmic reticulum.  X  10,000.  (b) Cell 
from W  3469 showing similar EM  features to McPc  1748.  Note  the prominent clusters of 
polysomes (arrows).  X  10,000. 
747 FxG. 3.  (a)  Cell from TEPC  183. Typical plasmacytoid cell with extensively developed 
rough surfaced  endoplasmic reticulum  and  numerous  intercisternal  A  particles.  )<  10,000. 
(b) Cell from McPc 774 with well developed rough surfaced endoplasmic reticulum and prom- 
inent intracisternai A type particles.  )<  10,000. 
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morphologically intermediate between the prototypes of groups I  and II cells, 
although somewhat closer to those of group II (Fig. 4 a and b). 
An additional feature noted by EM was the variability of expression of the 
frequently  described  murine  myeloma  associated  intracisternal  A  particles 
(19). In an extensive examination of McPc 1748 and W 3469 cells no particles 
of this type were noted. In striking contrast, the majority of TEPC  183  and 
McPc 774 cell profiles contained large numbers of particles in their character- 
istic intracellular distribution (Fig. 5 a, b). These were often observed in meta- 
phase cells. 
Biochemical Studies: Synthesis of of IgM-- 
Polypeptide  chains:  Cell  suspensions  of  the  mouse  tumors  McPc  1748, 
W  3469, TEPC  183, McPc 774,  and Y 5781  incorporated radioactive leucine 
linearly up to 6 h into total intracellular plus secreted protein and into immu- 
nologically precipitable IgM. Two distinct patterns of labeling of intracellular 
and secreted IgM were observed with the five tumor cell suspensions (Fig. 6). 
With  three group  II  tumor  cell  suspensions--TEPC  183,  McPc  774,  and 
Y 5781--equilibration of the intracellular pool of IgM with newly synthesized 
radioactive IgM molecules was reached after 4 h. Consequently a steady state 
in the rate of secretion of radioactive IgM was reached at the same time (Fig. 
6 c-e). All three tumors produced labeled ~- and L-chains in the expected molar 
ratios  as  judged  by  polyacrylamide gel  electrophoresis of  the  reduced  and 
alkylated radioactive IgM. 
With the two group I  tumor cell suspensions, McPc 1748 and W 3469, equil- 
ibration of the intracellular pool of IgM  with radioactive molecules  was  not 
achieved within the 6-h labeling period (Fig. 6 a and b). Very little radioactive 
IgM was secreted. This is particularly evident from the amount of radioactive 
IgM secreted at 4 h of labeling by these two tumor cells, when compared to the 
three actively secreting tumor cells McPc 774, TEPC 183, and Y 5781  (Table 
II). The tumors produced ~- and L-chains in the expected molar ratios. Any 
possible production of excess L  chain could again not be detected due to the 
k-L-chain specificity of our anti-IgM antiserum (see above). 
Carbohydrate moieties:  In close similarity to the results of the leucine-label- 
ing experiments, two distinct patterns of labeling of intracellular and secreted 
IgM  were observed with  incorporation of radioactive mannose  into  the  five 
tumor cell suspensions (Fig. 7). 
With the three group II tumor cells equilibration of the intracellular pool of 
IgM  with newly synthesized radioactive molecules was  reached after 4-5  h. 
Consequently a  steady state  in  the  rate  of secretion of IgM  molecules was 
reached at the same time (Fig. 7 c-e). 
With  the other two tumor cells,  McPc  1748 and W  3469, no equilibration 
of the intracellular pool of IgM with radioactive IgM molecules was reached 
within the 6-h labeling period. Very little IgM was secreted (Fig. 6, a  and b). 
The incorporated label was contained in the "core" sugars, glucosamines and FIG. 4.  (a)  Low power micrograph  of cells from  Y  5781 showing moderately  developed 
rough surface endoplasmic reticulum and  occasional intracisternal  A particles.  X  5,250.  (b) 
Cell from Y 5781. X  10,000. 
750 FIG. 5.  (a)  McPc 774.  )<  5,000 showing distribution of A particles in all cells of field.  (b) 
TEPC 183. >(  14,000. Higher power view of particle distribution and morphology. 
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FIG. 6.  Time-course of incorporation of [3H]leucine into intracellular (A) and extracellular 
(O) IgM of five IgM-producing tumor ceils. For details see the Materials and Methods. 
mannoses  as  analyzed  after  acid  hydrolysis of  the  labeled,  serologically  pre- 
cipitated  IgM  as  free-labeled  sugars  (see  Materials  and  Methods).  All  five 
tumor  IgMs carried  similar  amounts  of  labeled  mannose,  hence  of  "core" 
sugars. This could be judged from a comparison of the amount of leucine-label 
in  the  polypeptide  portions  with  the  amount  of mannose-label  in the  carbo- 
hydrate  portions  of  the  five  intracellular  IgM  molecules  (Table  III).  Poly- 
acrylamide gel  electrophoresis of the reduced and alkylated radioactive  intra- 
cellular IgM showed that the tz chains but not the L  chains carried the label, 
and thus the carbohydrate moieties. 
All five tumor cells, labeled for up to 6 h, contained very little galactose- or 
fucose-labeled  IgM  (Fig.  8).  The  data  in Table  II  show that  the  amount of 
galactose  and  fucose  radioactivity  in  4-h-labeled  intracellular  IgM  is  very 
small  and approximately  the same  for all five  tumor IgMs.  Also,  in compari- 
son  to  leucine  label,  intracellular  IgM  from  all  five  tumor  cells  carried  very 
little  galactose  or  fucose  label  (Table  III).  We  conclude,  that  as  in  MOPC 
104E  tumor cells  (20)  and mitogen-stimulated  B  cells  (12),  fucose  and galac- 
tose  residues  are  added just before,  or at  the time,  IgM  is  secreted  from  the 
cells. 
The three group II tumor cells--TEPC  183, McPc 774, and Y  5781--secreted 
galactose-  and  fucose-labeled  IgM  from  within the  first  30  rain  of labelings 
linearly up to 6  h. These  tumor cells secrete  large numbers of IgM  molecules TABLE II 
Rates of lgM Synthesis and Secretion and the Ratio of the Rates of Synthesis and Secretion of IgM 
Over Those of all Proteins in the Cell of Five Mouse Tumors as Compared to Small, Resting, 
Unstimulated  B cells taken from (4) and 72-h Mitogen-Stimulated  B  Cells taken from 
(5) in Labeling Experiments with [SH]Leucine, 
[3H]Mannose, [3H)Galactose, [3H]Fueose 
Cells 
.  _  IgM 
10  ~ X nH radioactivity 
(cpm/5 X 106 ceils incorporated 
in 4 h) 
Ratio of rates (IgM/total protein) 
Secreted  Intracellular  Secreted  Intracellular 
[3H]Leucine-labeling 
Small, resting unstimulated  13  15  0.050  0.015 
B cells 
McPc 1748  19  65  0.058  0.020 
W  3469  35  130  0.090  0.040 
TEPC  183  330  210  0.33  0.060 
McPc 774  210  200  0.56  0.140 
Y 5781  125  120  0.41  0.160 
72-h mitogen-stimulated  300  130  0.35  0.090 
B cells 
[3H]Mannose-labeling 
Small, resting, unstimu-  2  20  0.020  0.025 
lated B cells 
McPc 1748  4  52  0.030  0.045 
W 3469  8  50  0.045  0.045 
TEPC 183  52  54  0.185  0.10 
McPc 774  100  160  0.455  0.225 
Y 5781  70  72  0.35  0.18 
72-h mitogen-stimulated  60  80  0.20  0.15 
B cells 
[3H]Galactose-labeling 
Small, resting, unstimu-  ND  ND  --  -- 
lated B cells 
McPc 1748  7  4  0.016  0.003 
W 3469  12  8  0.030  0.004 
TEPC 183  28  3  0.175  0.012 
McPc 774  92  8  0.260  0.006 
Y 5781  92  4  0.305  0.013 
72-h mitogen-stimulated  20  2  0.30  0.04 
B cells 
[SH]Fucose-labeling 
Small, resting, unstimu-  ND  ND  --  -- 
lated B cells 
McPc 1748  2  1  0.006  0.020 
W  3469  2  2  0.050  0.050 
TEPC 183  64  8  0.540  0.050 
McPc 774  13  1.7  0. 210  0.036 
Y 5781  28  1  0.140  0.050 
72-h mitogen-stimulated  20  2  0.30  0.040 
B cells 
* Data also shown in Figs. 6-8. 
ND, not detectable. 
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ods. 
TABLE  III 
Ratios  of Radioaetivities  Incorporated  into  Carbohydrate Moieties  of IgM  ([3H]Mannose-, 
[3H]Galactose-, [3H]Fucose-Labeling) over those Incorporated into 
Polypeptide  Portions  of I gM ([aH]Leucine-Labeling) * 
Tumor 
Mannose/leucine  Galactose/leucine  Fucose/leucine 
Secreted  Intracellular  Secreted Intracellular  Secreted  Intracellular 
McPc  1748  0.21  0.80  0.37  0.06  0.10  0.015 
W 3469  0.23  0.39  0.34  0.06  0.06  0.015 
TEPC 183  0.17  0.49  0.09  0.03  0.19  0.073 
McPc  774  0.71  0.80  0.65  0.04  0.09  0.009 
Y 5781  0.56  0.60  0.74  0.03  0.22  0.008 
* Data taken from Table II, Fig. 6 a-e, Fig. 7 a-e, and Fig. 8 a-e. 
which contain the "terminal" sugars. Polyacrylamide gel electrophoresis of  the 
reduced  and  alkylated  gatactose-  and  fucose-labeled  IgM  molecules secreted 
by the three tumor cells showed that the/z-chains, but not the L  chains, carried 
the labels and therefore contained these "branch" sugars. 
The  amount  of  galactose-  and  fucose-labeled  IgM  found  in  the  secreted 0) 
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FIG. 8.  Time-course of incorporation of [3H]galactose (top)  and  [3H]fucose (bottom)  into 
intracellular (A) and extracellular (O) IgM of five IgM-producing tumor cells. For details 
see the Materials and Methods. 
material  of the McPc  1748 and W  3469 cells  was very small.  However,  when 
the ratios of galactose to leucine and fucose to leucine incorporated into secreted 
lgM  were  examined,  they  did not  differ  significantly  from  those  seen  in  the 
group II cells  (Table III). The similarity in these ratios seen in the two groups 
suggests  that  the  relatively  low  incorporation  of  branch  sugars  into  released 
IgM  is consistent  with  the small  amount of IgM  activity  secreted  during  the 
period of observation. 
It  was  apparent  that  there  was  more  radioactivity  in  galactose-labeled, 756  FIVE  IgM-PRODUCING MOUSE  TUMORS 
secreted McPc 774  and Y  5781  IgM than in TEPC  183 IgM  (Table III). It 
was  also  evident  that  radioactive fucose labels  TEPC  183  IgM  more  than 
McPc 774 and Y 5781 IgM (Table III). Analysis of the radioactivity contained 
in 5 h-fucose- or galactose-labeled secreted TEPC  183, McPc 774, and Y  5781 
IgM  showed that galactose was mainly incorporated into galactose positions 
and fucose mainly into fucose positions of the carbohydrate moieties of IgM. 
Hence these differences may reflect quantitative differences in the amount of 
certain sugar residues in carbohydrate moieties of IgM. Heterogeneity in car- 
bohydrate moieties of glycoproteins is a well-documented phenomemon (21). 
Ratios of rates of synthesis and secretion of IgM over the rates of synthesis and 
secretion of all cellular macromolecules:  In Table II the ratios of rates of syn- 
thesis and secretion of IgM  over those of all  labeled cellular macromolecules 
are  calculated  from  data  obtained  in  a  4-h  labeling  period  with  radioactive 
leucine, mannose, galactose, and fucose. The five tumor cells are compared to 
unstimulated and to 72-h stimulated B cells (4, 5). It is evident that in group I 
tumor  cells  (McPc  1748,  W  3469)  IgM  synthesis  and  secretion comprises  a 
much smaller part of the synthesis and secretion of all cellular macromolecules 
(between 2 and 4% of the intracellular and 6 and 9% of the secreted cpm in 
the four labeling  experiments)  than  in group II  tumor  cells  (between 6  and 
16% intracellular and 35 and 56% secreted). This  was  confirmed by the car- 
bohydrate incorporation studies. 
Turnover  of  newly  synthesized  IgM:  Fig.  9  shows  the  disappearance  of 
labeled IgM from the five tumor cells  when the five tumor cells were labeled 
for 4  h  with  radioactive leucine,  then  transferred  into  nonradioactive chase 
medium and the disappearance of labeled IgM from the cells and its appearance 
in the supernatant medium measured after various periods of chase time. 
In group I  cells (McPc 1748 and W 3469) most IgM disappears with a rela- 
tively long median disappearance time (between 8 and 15 h). In group II cells 
two populations of IgM  molecules are easily distinguishable.  One disappears 
with  a  median  time  of  1.5-3  h.  These rapidly  disappearing  IgM  molecules 
represent between 65  and  75 %  of all  intracellular labeled IgM  molecules in 
TEPC 183 and McPc 774 cells and 90% in Y 5781 cells. The remainder of the 
IgM molecules disappear slowly, in McPc 774 cells with a T1/2 between 8 and 
15 h. In TEPC 183 and Y 5781 cells the T1/2 of intracellular IgM in the second 
phase is 15-25 h. 
Stability  of IgM synthesis in the presence of Actinomycin  D:  The five tumor 
cells were tested for the resistance of their IgM synthesis to inhibition of acti- 
nomycin D.  Biosynthetic incorporation of radioactive leucine into IgM  was 
measured in the presence and absence of 0.5 t~g/ml  actinomycin D. The data 
in Fig.  10 are expressed as ratios of labeled amino acid incorporated into IgM 
to that incorporated into total cell protein during the same incubation period. 
The resistance of IgM synthesis to actinomycin D-inhibition relative to that ANDERSSON  ET  AL.  757 
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thereafter placed in nonradioactive medium. Release (turnover) of labeled IgM was followed 
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Materials and Methods. 
of all cellular proteins is slight in group I  cells but marked in TEPC  183, Y 
5781, and McPc 774 cells. 
DISCUSSION 
Myeloma cells and their protein products have played an important role in 
the analysis of antibody synthesis and structure.  It has been  assumed that 
myeloma tumors represent clones of antibody-forming cells which have become 
malignant but retain their differentiated function. Hence,  they can serve  as 
useful models for the study of processes which take place in normal Ig-synthe- 
sizing cells. 
The IgM-producing BALB/c tumors described here could be separated into 
two groups using a  number of morphologic and functional criteria.  Group [ 
cells had strong surface immunofluorescence with anti-# antiserum, few cyto- 
plasmic membrane-bound polysomes, and synthesized only a small portion of 
their total  cell protein as IgM. IgM synthesis was actinomycin D-sensitive. 
Its turnover was slow and intracellular equilibration of labeled precursors was 758  FIVE  IgM-PRODUCING  MOUSE TUMORS 
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difficult to attain. Although some 19S IgM was secreted, the amount was very 
small.  Intracisternal  A  particles  were  not  detectable  in  numerous  electron 
microscopic sections of these cells. 
Group  II  cells  had  little  surface  Ig  but  intense  intracellular  fluorescence 
when  cytoplasmic  staining  was  performed  with  the  same  anti-/~  antiserum. 
Electron microscopy demonstrated an extensively developed RER and promi- 
nent  Golgi zones. The synthetic  ratio of IgM  to total protein was  high,  and 
IgM turnover was rapid. IgM secretion was copious and its synthesis appeared 
to  be  relatively  resistant  to  actinomycin  D.  The  cells  obtained  from  these 
tumors contained substantial numbers of intracisternal A particles. 
Abundant intracytoplasmic  Ig  and  the lack  of surface-bound Ig  is  strictly 
correlated with the development  of the RER  in group II  cells.  Although the 
development  of  the  amount  of  rough  endoplasmic  reticulum  in  maturing  B 
lymphocytes may be  continuous the initiation of  the development  of it  may 
be a discernible event during B cells maturation. In fact, stimulation of normal 
B  lymphocytes  by  mitogens  in  the  absence  of  DNA  synthesis  leads  to  the ANDERSSON  ET  AL.  759 
development of immature plasmablasts with numerous  intracytoplasmic  poly- 
ribosomes,  but  no  visible RER  (22).  These  cells resemble  the  group  I  tumor 
cells.  Upon  release  of  the  DNA  synthesis  inhibition,  cells  develop,  which  re- 
semble group II tumor cells.  It appears likely that  the  analysis of more IgM- 
producing  tumor  cells  will  more  clearly  distinguish  two  groups  (I  and  II), 
which are discontinuous  with each other. 
The  clear  distinction  between  these  two  groups of IgM-synthesizing  tumor 
cells prompted a  comparison of their morphologic and functional  features with 
those  of lipopolysaccharide  (LPS)-stimulated  B  cells  (5, 6).  Extensive  studies 
had  indicated  that  when  normal  murine  B  cells  were  exposed  to  this  B-cell 
mitogen,  they  increased  their  cytoplasmic  volume,  developed  an  extensive 
RER  with its associated polyribosomes and became more plasmacytoid  (1,  2). 
Analysis of protein synthesis in these cells has demonstrated  that  the amount 
of Ig synthesis (as IgM) relative to total cell protein synthesis increased mark- 
edly. The turnover of the cell-associated IgM became more rapid as the major 
portion  of the newly  synthesized  molecules was secreted  without  delay.  Acti- 
nomycin  D  appeared  to  have  little  effect on  IgM  synthesis  later  in  the  re- 
sponse  (5). 
Fig.  11  demonstrates  the relationship between each of the tumors and LPS- 
stimulated  B  cells.  The data obtained  from the  amino  acid  and  carbohydrate 
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labeling  experiments  with  each  tumor  have  been  superimposed  on  curves 
derived  from  identical  experiments  performed  with  stimulated  B  cells  (5). 
McPc  1748 is analogous  to a  10-20 h  LPS-stimulated spleen cell  suspension 
while McPc 774 closely resembles a 100-120 h stimulated cell suspension. None 
of the tumors studied in this group appear to represent an unstimulated B cell. 
Group I  tumor  cells,  like  early B  cells,  had  most  of their  cell-associated 
IgM at the surface. Initially they released IgM at a slower rate than group  II 
cells  which  secrete  their  immunoglobulin  with  kinetics  similar  to  mature 
plasma  cells.  After 6  h,  the rates became similar  as  the pace of release  was 
slowed in the late B-cell tumors. This biphasic release of cell-associated  IgM 
could be explained either by the presence of two distinct populations of IgM 
molecules, maybe in two different populations of cells,  or by the  equilibration 
of labeled and unlabeled subunits in the face of a random assembly and  secre- 
tion process, in which the 8S subunits are not assembled into polymers in  the 
order in which they are synthesized. 
The possibility that two separate populations of IgM molecules could result 
from  a  separate  regulation  of  the  biosynthesis  of  membrane-bound  and  of 
secreted Ig is also supported by the differences observed in synthesis and  turn- 
over of IgM in resting and in mitogen-activated B lymphocytes (4, 5), by the 
difference in size and carbohydrate composition of these different types of IgM 
(4, 5), and by studies with another mouse myeloma cell producing membrane- 
bound and secreted IgG (23). The problem of the intracellular segregation of 
Ig chains and their direction to either a  surface or a  secretory pool may be 
approached using the tumor cells as models. 
Comparison of the kinetics of incorporation of various labeled sugars  into 
the IgM  of the group I  and II  tumor cells indicated  that  molecules bearing 
the terminal sugars may have been associated with the cells for a longer period 
of time in group I  cells.  Although  the carbohydrate composition of the  cell- 
associated IgM  was not chemically determined, the sugar  to leucine ratio of 
the  IgM  secreted by  each of the  tumors  revealed no  systematic  differences 
between group I  and group II  cells In  both groups  the sugar  residues  were 
associated  exclusively with  the  /~-chains,  however the  labeling  pattern  sug- 
gested that  there may be variations in  the carbohydrate composition within 
groups I  and II. 
The apparent  dichotomy of effect of actinomycin D  in  the  two groups of 
tumors  was  quite  striking.  The lack  of sensitivity in  group  II  argues  for a 
longer period of utilization of preformed mRNA by these cells.  Recent studies 
in Hela and L  cells have indicated that this is probably not a function of mes- 
senger degradation but may represent a failure of re-initiation along the same 
mRNA molecules. This may be a function of the number or nature of the cyto- 
plasmic ribosomes or some other, as yet undetermined, factor (24,  25). 
It is difficult to interpret the biologic behavior of the tumors with respect 
to the relative maturity of the cells as a B lymphocyte. Animals bearing group ANDERSSON  ET AL.  761 
I  tumors have enormously enlarged infiltrated spleens. When these spleens are 
passed into new animals 100 % of the recipients develop tumors. Spleens from 
group II-bearing animals produce tumors in a minority of recipients. This may 
reflect some variation in the surface or migratory properties of B  cells at dif- 
ferent stages of maturation. 
The final striking disparity between group I  and group II  cells was in the 
presence of intracisternal  A  particles.  We have  been unable  to  detect these 
particles in many examinations of group I  cells,  while they are  abundant  in 
in group II cells. The particles do not bear a direct relationship to the prolifera- 
tive capacity of the cells,  since both tumor types were fatal. Previous workers 
have attempted to correlate the presence of the particles with  Ig production 
(26); however, EM studies of non-Ig-producing lines cloned from the MPC  11 
tumor revealed large numbers of particles (27). The ability to synthesize Ig is 
not  an  absolute  requirement  for  their  expression.  This  difference  between 
group I  and II cells may not be qualitative, but even if it represents a quan- 
titative difference, there may be some process involved in B-cell maturation 
which  allows the flagrant expression of these presumably viral  elements only 
by the more mature numbers of the series. In conclusion, it appears that these 
IgM-producing BALB/c tumors represent various stages of B-cell maturation 
which have been retained despite the malignant state. They should serve as a 
useful model for examining the process of B-cell maturation which results in 
the IgM antibody-secreting cell. 
SUMMARY 
Five  adjuvant  induced  BALB/c  tumors  producing  IgM--McPc  1748, 
W  3459, TEPC  183, McPc  774, and Y  5781--were  characterized morpho- 
logically  by electron  microscopy, analysis  of the distribution  of surface-bound 
and intracytoplasmic IgM  using immunofluorescence, and by biochemical 
study of IgM synthesis,  turnover,  and secretion.  The cells  of different  tumors 
appear to represent different  stages  in B-cell  maturation when'compared  to 
normal, lipopolysaccharide-stimulated  B  cells.  Thus, McPc  1748 tumor cells 
resemble 10-25-h stimulated  normal B cells,  3469 cells  resemble 20-35-h  stim- 
ulated B  cells,  TEPC  183 cells  resemble 45-55-h stimulated B  cells,  Y  5781 
cells  resemble 80-110-h stimulated  B cells,  and McPc 774 cells  resemble 100- 
130-h stimulated  B cells. 
The able  technical  assistance  of  Misses M. Gidlund,  Dorothee Jablonski,  Ingrld M611eg~,rd 
Rosmary Chou, and Susan Dittmar is  gratefully  acknowledged. 
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